In fact, high SK1 mRNA expression levels are associated with a better prognosis in patients with luminal A, luminal B and HER2+ breast cancer subtype, however the evaluation of all breast cancer patients did not indicate a connection between SK1 and RFS, suggesting that in certain subtypes of breast cancer patients SK1 expression could be beneficial for the patients. The gene discussed is ERBB2; the disease is breast carcinoma.